<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3692545&amp;fmt=gif">

What is the Off-Ramp for a Harm Reduction Strategy?

Michael Brown
Michael Brown
Michael W. Brown is the global director of counter-narcotics technology at Rigaku Analytical Devices. He has a distinguished career spanning more than 32 years as a Special Agent for the Drug Enforcement Administration (DEA). Most recently he was the DEA Headquarters staff coordinator for the Office of Foreign Operations for the Middle East-Europe-Afghanistan-India. Prior to that he served as the country attaché in India and Myanmar providing foreign advisory support for counter narcotic enforcement. He also spent 10 years in Pakistan as a special advisor to the US Embassy on various law enforcement issues. Michael is a graduate of the United States Ranger Training Battalion and has a master’s degree in Interdisciplinary Technology and Management from the University of Eastern Michigan.
    

 

This episode features a discussion with Sofia Georgoulias Psy.D, a clinical psychologist based out of New York. She has extensive experience treating patients with substance abuse issues, general mental health and harm reduction. She also has a direct line of sight into our legal system, specifically incarcerations, from her time working at Rikers Island. 

Michael Brown and Jen Lynch speak to Sofia about: 

  • The research and rationale behind harm reduction strategies  
  • The long terms effectiveness of safe injection sites 
  • Is there an off-ramp when implementing a harm reduction strategy?

 

 

Views expressed in this material are opinions of the host and the guest, and do not necessarily reflect the views of Rigaku Analytical Devices.

Listen and subscribe on your favorite podcast player:

Apple Podcasts

Spotify


To make sure you never miss an episode of The Opioid Matrix, subscribe on Apple Podcasts, Spotify, the website, or your favorite podcast player here: https://plinkhq.com/i/1625927161?to=page